The Jembrana disease virus Rev protein: Identification of nuclear and novel lentiviral nucleolar localization and nuclear export signals.
Amino Acid Motifs
Amino Acid Sequence
Animals
Cattle
Cell Line
Cell Nucleolus
/ metabolism
Dogs
Gene Products, rev
/ chemistry
Green Fluorescent Proteins
/ metabolism
HEK293 Cells
Humans
Lentivirus
/ metabolism
Mutant Proteins
/ metabolism
Nuclear Export Signals
Nuclear Localization Signals
/ chemistry
Protein Transport
Recombinant Fusion Proteins
/ metabolism
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2019
2019
Historique:
received:
23
04
2018
accepted:
08
08
2019
entrez:
23
8
2019
pubmed:
23
8
2019
medline:
4
3
2020
Statut:
epublish
Résumé
The lentiviral Rev protein, which is a regulatory protein essential for virus replication, has been first studied in the human immunodeficiency virus type 1 (HIV-1). The main function of Rev is to mediate the nuclear exportation of viral RNAs. To fulfill its function, Rev shuttles between the cytoplasm and the nucleus. The Jembrana disease virus (JDV), a lentivirus, is the etiologic agent of the Jembrana disease which was first described in Bali cattle in Indonesia in 1964. Despite the high mortality rate associated with JDV, this virus remains poorly studied. Herein the subcellular distribution of JDV Rev, the nuclear and nucleolar localization signals (NLS and NoLS, respectively) and the nuclear export signal (NES) of the protein were examined. JDV Rev fused to the enhanced green fluorescent protein (EGFP) predominantly localized to the cytoplasm and nucleolus of transfected cells, as determined by fluorescence microscopy analyses. Through transfection of a series of deletion mutants of JDV Rev, it was possible to localize the NLS/NoLS region between amino acids (aa) 74 to 105. By substituting basic residues with alanine within this sequence, we demonstrated that the JDV Rev NLS encompasses aa 76 to 86, and is exclusively composed of arginine residues, whereas a bipartite NoLS was observed for the first time in any retroviral Rev/Rev-like proteins. Finally, a NES was identified downstream of the NLS/NoLS and encompasses aa 116 to 128 of the JDV Rev protein. The JDV Rev NES was found to be of the protein kinase A inhibitor (PKI) class instead of the HIV-1 Rev class. It also corresponds to the most optimal consensus sequence of PKI NES and, as such, is novel among lentiviral Rev NES.
Identifiants
pubmed: 31437223
doi: 10.1371/journal.pone.0221505
pii: PONE-D-18-12227
pmc: PMC6706053
doi:
Substances chimiques
Gene Products, rev
0
Mutant Proteins
0
Nuclear Export Signals
0
Nuclear Localization Signals
0
Recombinant Fusion Proteins
0
enhanced green fluorescent protein
0
Green Fluorescent Proteins
147336-22-9
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0221505Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Proc Natl Acad Sci U S A. 1999 Nov 9;96(23):13404-8
pubmed: 10557333
Exp Cell Res. 2000 Apr 10;256(1):213-24
pubmed: 10739668
Virology. 2000 Aug 15;274(1):11-6
pubmed: 10936083
Arch Virol. 2002 Mar;147(3):643-9
pubmed: 11958463
Eur J Biochem. 2002 Jun;269(11):2727-34
pubmed: 12047381
Virology. 2002 Dec 5;304(1):10-23
pubmed: 12490399
Comp Immunol Microbiol Infect Dis. 2003 Mar;26(2):89-101
pubmed: 12493490
J Virol. 1992 Feb;66(2):1074-83
pubmed: 1309889
Mol Cell Biol. 2003 Dec;23(23):8751-61
pubmed: 14612415
Vet Microbiol. 1992 Nov;33(1-4):367-74
pubmed: 1481364
J Biol Chem. 2004 Jun 18;279(25):26563-70
pubmed: 15060081
Virology. 2004 Apr 25;322(1):190-8
pubmed: 15063128
J Biol Chem. 2004 Jun 18;279(25):26666-73
pubmed: 15067009
Protein Eng Des Sel. 2004 Jun;17(6):527-36
pubmed: 15314210
Virology. 2005 Jun 20;337(1):1-6
pubmed: 15914215
J Virol. 2006 Apr;80(8):3844-52
pubmed: 16571801
Trends Biochem Sci. 1991 Dec;16(12):478-81
pubmed: 1664152
J Biol Chem. 2007 Feb 23;282(8):5101-5
pubmed: 17170104
FEBS Lett. 2007 Oct 30;581(26):5070-4
pubmed: 17923126
Virus Res. 2008 Aug;135(2):336-9
pubmed: 18466992
Virology. 2008 Oct 25;380(2):191-202
pubmed: 18775548
J Biol Chem. 2009 Jan 2;284(1):478-85
pubmed: 19001369
J Virol. 1991 Nov;65(11):6001-7
pubmed: 1920623
EMBO Rep. 2009 Mar;10(3):231-8
pubmed: 19229283
Virology. 2009 Apr 10;386(2):310-6
pubmed: 19230948
J Virol. 2009 Dec;83(24):12842-53
pubmed: 19828621
J Virol. 1991 Apr;65(4):2131-4
pubmed: 2002556
Traffic. 2010 Mar;11(3):311-23
pubmed: 20028483
Mol Cell Biol. 1991 May;11(5):2567-75
pubmed: 2017166
Curr HIV Res. 2010 Jan;8(1):2-13
pubmed: 20210777
Curr HIV Res. 2010 Jan;8(1):53-65
pubmed: 20210780
Nat Struct Mol Biol. 2010 Nov;17(11):1367-76
pubmed: 20972448
J Virol. 2012 May;86(9):4892-905
pubmed: 22379104
PLoS One. 2012;7(6):e38305
pubmed: 22675540
Vet Immunol Immunopathol. 2012 Oct 15;149(3-4):167-76
pubmed: 22776774
J Virol. 1990 Feb;64(2):881-5
pubmed: 2404140
Biochim Biophys Acta. 2014 Jun;1842(6):840-7
pubmed: 24378568
J Gen Virol. 1989 Jul;70 ( Pt 7):1617-39
pubmed: 2544657
J Biol Chem. 1989 Oct 25;264(30):18019-23
pubmed: 2553699
Cell Microbiol. 2015 Aug;17(8):1108-20
pubmed: 26041433
Biochem Biophys Res Commun. 1989 Aug 15;162(3):963-70
pubmed: 2788417
J Gen Virol. 2017 Apr;98(4):563-576
pubmed: 28056216
Elife. 2017 Mar 10;6:
pubmed: 28282025
Virology. 2018 Feb;515:158-164
pubmed: 29289827
Nucleic Acids Res. 1995 May 25;23(10):1647-56
pubmed: 7540284
Cell. 1995 Aug 11;82(3):475-83
pubmed: 7543368
Biotechniques. 1995 May;18(5):746-50
pubmed: 7619468
Vet Immunol Immunopathol. 1995 Apr;45(3-4):211-20
pubmed: 7676607
J Gen Virol. 1993 Sep;74 ( Pt 9):1765-78
pubmed: 7690840
J Mol Biol. 1997 Dec 19;274(5):693-707
pubmed: 9405152
Mol Cell Biol. 1998 Jul;18(7):3889-99
pubmed: 9632773
Exp Cell Res. 1998 Aug 1;242(2):540-7
pubmed: 9683540
J Virol. 1998 Sep;72(9):7593-7
pubmed: 9696859
J Virol. 1998 Nov;72(11):8627-35
pubmed: 9765402
J Biol Chem. 1998 Dec 11;273(50):33414-22
pubmed: 9837918
Annu Rev Microbiol. 1998;52:491-532
pubmed: 9891806